Combined Pre- and Post-surgical Bupivacaine Wound Infiltrations Decrease Opioid Requirements After Knee Ligament Reconstruction
Overview
Affiliations
Purpose: To test the efficacy of a combination of selective pre- and post-surgical local anesthetic infiltrations of the knee, compared with standard intra-articular injection at the end of surgery alone, to reduce postoperative opioid requirements following arthroscopic cruciate ligament reconstruction (ACLR).
Methods: In a double-blind, randomized, controlled trial, we studied 23 patients (ASA I or II) scheduled for elective ACLR under general anesthesia. The treatment group (n = 12) received infiltrations with bupivacaine 0.25% with epinephrine 1:200,000 presurgically (10 ml into the portals, 10 ml at the medial tibial incision site, 10 ml at the lateral femoral incision site, and 10 ml intra-articularly) and postsurgically (5 ml at the medial tibial incision and 10 ml at the lateral femoral incision). The control group (n = 11) received infiltrations with saline 0.9% in the same manner. All patients received a standard intra-articular local anesthetic instillation of the knee (25 ml of bupivacaine 0.25% with epinephrine 1:200,000) at the completion of surgery.
Results: Postoperative opioid requirements were lower in the treatment group (5.8 +/- 2.9 mg morphine equivalent) than in the control group ( 13.7 +/- 5.8 mg; P = 0.008). Treatment patients were ready for discharge approximately 30 min earlier than control patients (P = 0.046). There were no adverse events in the treatment group. In the control group, 2/11 patients vomited and a third experienced transient postoperative diaphoresis, dizziness and pallor.
Conclusion: We conclude that a combination of selective pre- and post-surgical wound infiltration with bupivacaine 0.25% provides superior analgesia compared with a standard post-surgical intra-articular injection alone.
Reduction of opioid use after orthopedic surgery: a scoping review.
Gormley J, Gouveia K, Sakha S, Stewart V, Emmanuel U, Shehata M Can J Surg. 2022; 65(5):E695-E715.
PMID: 36265899 PMC: 9592092. DOI: 10.1503/cjs.023620.
A controlled release bupivacaine-alginate construct: Effect on chondrocyte hypertrophy conversion.
Davis M, Marrero-Berrios I, Perez X, Radhakrishnan P, Manchikalapati D, Ahmed K Osteoarthr Cartil Open. 2022; 2(4).
PMID: 35392127 PMC: 8986124. DOI: 10.1016/j.ocarto.2020.100125.
Control Release Anesthetics to Enable an Integrated Anesthetic-mesenchymal Stromal Cell Therapeutic.
Maguire T, Davis M, Marrero-Berrios I, Zhu C, Gaughan C, Weinberg J Int J Anesthesiol Pain Med. 2019; 2(1).
PMID: 31106286 PMC: 6519947. DOI: 10.21767/2471-982X.100012.
Clifford J, Mares A, Hansen J, Averitt D BMC Anesthesiol. 2015; 15:135.
PMID: 26444970 PMC: 4596364. DOI: 10.1186/s12871-015-0113-x.
Pinheiro L, Neri Junior E, Fernandes R, Cardozo R, Rezende P Rev Bras Ortop. 2015; 50(3):300-4.
PMID: 26229934 PMC: 4519662. DOI: 10.1016/j.rboe.2015.06.002.